Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk
- 1 August 2005
- journal article
- cancer
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 20 (8) , 699-711
Abstract
Objectives: Hormone-replacement therapy (HRT) is an established risk factor for breast cancer. HRT users are different from non-users with respect to socio-economic and other characteristics. There may be women where the HRT-related risk could be modulated by other factors. Methods: We conducted a population-based case–control study with 688 breast cancer cases and 724 controls to characterize HRT users and to estimate odds ratios (OR) and 95% confidence intervals (CI) for HRT use and potentially risk modifying factors. Results: In women aged 50 years and older, 58% of controls and 61% of cases ever used HRT. Among women in natural menopause, HRT use for 10 years and more years was associated with an increased breast cancer risk (OR 1.79, 95% CI, 1.12–2.87), but not among women in surgical menopause (OR 0.61, 95% CI, 0.09–4.17). In the subgroup of women with a positive family history of breast cancer, each year of HRT use increased the risk by 1.22 (95% CI, 1.02–1.47). Another subgroup comprised women with at least 10 diagnostic mammograms (OR 4.04, 95% CI, 1.10–14.81 for using HRT 10 or more years). Conclusions: Long-term HRT use was associated with a breast cancer risk in women with natural menopause. Our findings suggest that this risk may be increased in women with a positive family history of breast cancer and in women who received frequent diagnostic mammographic screens.Keywords
This publication has 35 references indexed in Scilit:
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Hormone replacement therapy and cancer risk: A systematic analysis from a network of case‐control studiesInternational Journal of Cancer, 2003
- Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in SwedenCancer, 2003
- Hormone Replacement Therapy Dissociates Fat Mass and Bone Mass, and Tends to Reduce Weight Gain in Early Postmenopausal Women: A Randomized Controlled 5-Year Clinical Trial of the Danish Osteoporosis Prevention StudyJournal of Bone and Mineral Research, 2003
- Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000BJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Hormonersatztherapie - Therapie mit RisikenDMW - Deutsche Medizinische Wochenschrift, 2001
- PC-gestützte Datenerhebung als Beitrag zur Qualitätssicherung in Gesundheitssurveys: Erfahrungen mit DAIMON im KORA-Survey 2000Journal of Public Health, 2000
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Mammography Adherence and Psychological Distress Among Women at Risk for Breast CancerJNCI: Journal of the National Cancer Institute, 1993